Company / SG&A per Share
Repligen SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$5136.19
FY2025
5-year range
$3210.85 / $5136.19
FY2021-FY2025
Trend
+9.1%
vs FY2024
Sector context
#1 of 210
Health Care
What the data says
Among 210 Health Care companies, Repligen is in the bottom 0% for sg&a per share. SG&A per Share has increased for 7 consecutive years, from $1.44 in FY2018 to $5136.19 in FY2025.
Based on SEC 10-K filings.
5136.19 in FY2025 with a 5-year CAGR of +18.3%. Ranks 1st among 210 companies in Health Care.
Increased from $3877.18 to $5136.19 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +11.0%
- 5-Year CAGR
- +18.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 0% in Health CareTop 100% of 210This company $5136.19 Sector average $29.50
▼
+17309.6% above sector average
Key checks
Key Insights
- Repligen's sg&a per share has grown for 7 consecutive years.
- In FY2025, sg&a per share increased 9.1% year-over-year.
- Ranks #1 out of 210 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2016.
Company context
Key Data Points
- Negative profit margin: -18.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5136.19 | +9.1% |
| FY2024 | $4708.30 | +21.4% |
| FY2023 | $3877.18 | +3.2% |
| FY2022 | $3756.49 | +17.0% |
| FY2021 | $3210.85 | +44.7% |
| FY2020 | $2219.64 | +114131.1% |
| FY2019 | $1.94 | +34.5% |
| FY2018 | $1.44 | -5.1% |
| FY2017 | $1.52 | +62.5% |
| FY2016 | $0.94 | +141.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026